Inhibition of insulin-induced chondrogenic differentiation of embryonic carcinoma cells by a teratogenic compound YM9429

Biochemical and Biophysical Research Communications

Volumn 225, Issue 2, 1996, Pages 593-599

  Shibata, Masakatsu ^a   Fujino, Emi ^b   Sato, Yoichi ^b   Numazawa, Satoshi ^b   Yoshida, Takemi ^b   Kuroiwa, Yukio ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; COLLAGEN TYPE 2; CYCLIC AMP; INSULIN; TERATOGENIC AGENT; UNCLASSIFIED DRUG; YM 9429;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHEMICAL TERATOGENESIS; CHONDROGENESIS; CLEFT PALATE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; EARLY RESPONSE GENE; EMBRYO; EMBRYONAL CARCINOMA; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030583245     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1216     Document Type: Article

References (22)

1. 1. Flint, O. P., and Orton, T. C. (1984) Toxicol. Appl. Pharmacol. 76, 383-395.
2. 2. Tsuchiya, T., Nakamura, A., Iio, T., and Takahashi, A. (1991) Toxicol. Appl. Pharmacol. 109, 1-6.
3. 3. Aulthouse, A. L., and Hitt, D. C. (1994) Teratology 49, 208-217.
4. 4. Andrews, J. E., Ebron-McCoy, M., Bojic, U., Nau, H., and Kavlock, R. J. (1995) Toxicol. Appl. Pharmacol. 132, 310-316.
5. 5. Welsch, F. (1992) Teratology 46, 3-14.
6. 6. Atsumi, T., Miwa, Y., Kimata, K., and Ikawa, Y. (1990) Cell Diff. Dev. 30, 109-116.
7. 7. Shukunami, C., Shigeno, C., Atsumi, T., Ishizeki, K., Suzuki, F., and Hiraki, Y. (1996) J. Cell Biol. 133, 457-468.
8. 8. Shibata, M. (1993) J. Toxicol. Sci. 18, 171-178.
9. 9. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R. (1988) Cancer Res. 48, 4827-4833.
10. 10. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
11. 11. Numazawa, S., Inoue, N., Nakura, H., Sugiyama, T., Fujino, E., Shinoki, M., Yoshida, T., and Kuroiwa, Y. (1996) Biochem. Pharmacol. 52, in press.
12. 12. van Straaten, F. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 3183-3187.
13. 13. Kitabayashi, I., Saka, F., Gachelin, G., and Yokoyama, K. (1990) Nucleic Acid Res. 18, 3400.
14. 14. Maehara, Y., Fujiyoshi, T., Takahashi, K., Yamamoto, M., and Endo, H. (1985) Biochem. Biophys. Res. Commun. 131, 800-805.
15. 15. Juchau, M. R. (1993) in Progress in Drug Research (Jucker, E., Ed.), Vol. 41, pp. 9-50, Birkhäuser Verlag, Basel.
16. 16. D'Amato, R. J., Loughnan, M. S., Flynn, E., and Folkman, J. (1994) Proc. Natl. Acad. Sci. 91, 4082-4085.
17. 17. Hill, D. J. (1992) Horm. Res. 38, 197-202.
18. 18. Morrison Graham, K., Schatteman, G. C., Bork, T., Bowenpope, D. F., and Weston, J. A. (1992) Development 115, 133-142.
19. 19. Duester, G. (1991) Alcohol Clin. Exp. Res. 15, 568-572.
20. 20. Shibata, M. and Eatanabe, T. (1995) J. Toxicol. Sci. 20, 9-14.
21. 21. Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Cell 75, 59-72.
22. 22. Baker, J., Liu, J.-P., Robertson, E. J., and Efstratiadis, A. (1993) Cell 75, 73-82.